India · Delayed Price · Currency is INR Global Health Statistics
Total Valuation
Global Health has a market cap or net worth of INR 377.93 billion. The enterprise value is 378.75 billion.
| Market Cap | 377.93B |
| Enterprise Value | 378.75B |
Important Dates
The last earnings date was Thursday, July 30, 2026.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | Aug 22, 2025 |
Share Statistics
| Current Share Class | 268.87M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.43% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 43.79% |
| Owned by Institutions (%) | 22.94% |
| Float | 88.51M |
Valuation Ratios
The trailing PE ratio is 67.95 and the forward PE ratio is 50.63.
| PE Ratio | 67.95 |
| Forward PE | 50.63 |
| PS Ratio | 8.07 |
| PB Ratio | 9.49 |
| P/TBV Ratio | 9.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 52.90 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 68.10 |
| EV / Sales | 8.09 |
| EV / EBITDA | 39.12 |
| EV / EBIT | 51.71 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 1.23 |
| Debt / FCF | -9.61 |
| Interest Coverage | 7.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.89% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 4.56M |
| Profits Per Employee | 542,084 |
| Employee Count | 10,260 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Global Health has paid 1.68 billion in taxes.
| Income Tax | 1.68B |
| Effective Tax Rate | 23.30% |
Stock Price Statistics
The stock price has increased by +7.80% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +7.80% |
| 50-Day Moving Average | 1,294.96 |
| 200-Day Moving Average | 1,197.92 |
| Relative Strength Index (RSI) | 65.10 |
| Average Volume (20 Days) | 19,837 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Global Health had revenue of INR 46.83 billion and earned 5.56 billion in profits. Earnings per share was 21.20.
| Revenue | 46.83B |
| Gross Profit | 24.72B |
| Operating Income | 7.32B |
| Pretax Income | 7.20B |
| Net Income | 5.56B |
| EBITDA | 9.68B |
| EBIT | 7.32B |
| Earnings Per Share (EPS) | 21.20 |
Balance Sheet
The company has 11.30 billion in cash and 11.90 billion in debt, with a net cash position of -598.18 million.
| Cash & Cash Equivalents | 11.30B |
| Total Debt | 11.90B |
| Net Cash | -598.18M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 39.84B |
| Book Value Per Share | 147.47 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 7.14 billion and capital expenditures -8.38 billion, giving a free cash flow of -1.24 billion.
| Operating Cash Flow | 7.14B |
| Capital Expenditures | -8.38B |
| Depreciation & Amortization | 2.36B |
| Net Borrowing | 3.44B |
| Free Cash Flow | -1.24B |
| FCF Per Share | n/a |
Margins
Gross margin is 52.79%, with operating and profit margins of 15.64% and 11.88%.
| Gross Margin | 52.79% |
| Operating Margin | 15.64% |
| Pretax Margin | 15.38% |
| Profit Margin | 11.88% |
| EBITDA Margin | 20.67% |
| EBIT Margin | 15.64% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.03%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.03% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.43% |
| Shareholder Yield | 2.46% |
| Earnings Yield | 1.47% |
| FCF Yield | -0.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Global Health is 1,476.41, which is 3.60% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,476.41 |
| Price Target Difference | 3.60% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 15.95% |
| EPS Growth Forecast (3Y) | 22.24% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |